Skip to Content
Skip to Search
Media release: Q4 & FY21-22
Outcome of the Board Meeting
Disclosure under Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Completion of Sale of Company's trademarks 'pertaining to 'lodex' and 'Ostocalcium' Brands in India
Media release: Q3 of 2021-22
Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021
Related Party Transaction as on 30.09.2021
Completion of Sale of Company’s Manufacturing Facility located at Vemgal, Karnataka
Change in email ID for Investor Communication
Analyst Meet November 2021
Outcome of the board meeting on October 29, 2021
Media release: Quarter ended September 30, 2021
Statement of Standalone Unaudited Financial Results for the Quarter and Six Months ended 30th September, 2021
Statement of Consolidated Unaudited Financial Results for the Quarter and Six Months ended 30th September, 2021
Board Meeting Intimation - Un-Audited Financial Results for the second quarter and half year ended 30th September 2021
Trading window closure - October 2021
Presentation of Analyst/ Institutional Investor Meetings
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations
Media release: Q1 of 2021-22
Outcome of the Board Meeting
Un-Audited Financial Results for the first quarter ended 30th June 2021
Closure of 'Trading Window'
Intimation of Record Date pursuant to Regulation 42 of the Securities and Exchange Board of India (LODR) Regulations, 2015
Outcome of meeting dt 18 May 2021
Media release: Q3 and FY20-21
Un- Audited Financial Results for the quarter and nine months ended 31 st December 2020
Closure of Trading Window
Media release: Q2 FY20-21
Outcome of Board Meeting - October 2020
Un- Audited Financial Results for the quarter and six months ended 30th September 2020
Closure of Trading Window
Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations
Outcome of Board meeting - July 2020
Disclosure of Voting Results and Outcome of the 95th Annual General Meeting of the Company
Discontinuation of supply of Ranitidine products
Media release: Q4 FY19-20
Outcome of the Board Meeting
Outcome of Board Meeting March 2020
Press release - New MD appointment
Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2019
Media release: Quarter ended 31st December 2019
Trading window closure February 2020
Board Meeting Intimation February 2020
Outcome of Board Meeting October 2019
Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations
Submission of Disclosure on Related Party Transactions
Trading window closure October 2019
Board Meeting Intimation October 2019
Update on the Company's Ranitidine Product
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - September 5, 2019
Approval of Sale of Company's land at Thane, Maharashtra 30/8 - August 30, 2019
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 12, 2019
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 12, 2019
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 1, 2019
Outcome of Board Meeting July 2019
Outcome of Board Meeting - May 2019
Intimation of Book Closure 2019
Board Meeting Intimation - May 20, 2019
Change in Directorate - March 28, 2019
Outcome of the Board Meeting
Board Meeting Intimation - February 4, 2019
Board Meeting Intimation Oct 2018
Publication of Add of Record Date for Bonus Issue of Shares
Record Date for Bonus Issue of Equity Shares
Board Meeting Intimation July 24, 2018
Board Meeting Intimation May 24, 2018
Board Meeting Intimation February 02, 2018
Change in Directorate - 25th October, 2017
Board Meeting Intimation October 25, 2017
Outcome of AGM 2017 and Voting Results
Board Meeting Intimation July 25, 2017
Publication of Evoting and Book Closure Notice
Board Meeting Intimation May 19, 2017
Disclosures of castleton and GSK PTE
Change in Directorate - 7 April, 2017
Board Meeting Intimation 11-02-2017
Notice of Board Meeting - 27/10/2016
Outcome of AGM and Voting Results
Notice of Business Meeting - 28/07/2016
Publication of Notice regarding e-voting in Newspapers